


September 2023 Top Biopharma Deal: Immatics development and commercialization deal with Moderna for TCR therapies

August 2023 Top Biopharma Deal: Poseida license option deal with Astellas for P-MUC1C-ALLO1

July 2023 Top Biopharma Deal: Alnylam co-development and co-commercialization deal with Roche for zilebesiran

June 2023 Top Biopharma Deal: AstraZeneca research partnership with Quell Therapeutics with an option to license Treg cell therapies
